Receptor-mediated radiotherapy with 90Y-DOTA-DPhe1-Tyr3-octreotide: The experience of the European Institute of Oncology Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Receptor-mediated radiotherapy with 90Y-DOTA-DPhe1-Tyr3-octreotide: The experience of the European Institute of Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences